Who owns IMMUNOME INC?
- Ticker: IMNM
- CUSIP Number: 45257u108
Tip: Access positions for across all investors
Analyze quarterly positions in Immunome with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Immunome stock
Who bought or sold IMMUNOME INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EcoR1 Capital | 3.9M | $42M | 100% | Dec 2023 |
|
| Redmile Group | 3.9M | $42M | 100% | Dec 2023 |
|
| Vanguard Group | 1.7M | $19M | 339% | Dec 2023 |
|
| Henderson Group | 1.4M | $15M | 100% | Dec 2023 |
|
| Avidity Partners Management | 1.3M | $14M | 100% | Dec 2023 |
|
| T. Rowe Price Associates | 1.1M | $11M | 505% | Dec 2023 |
|
| Point72 Asset Management | 683k | $7.3M | 25% | Dec 2023 |
|
| Brown Advisory Holdings Incorporated | 670k | $17M | 100% | Mar 2024 |
|
| Alpine Partners VI | 192k | $2.1M | -47% | Dec 2023 |
|
| TD Asset Management | 127k | $1.4M | 0% | Dec 2023 |
|
| Prentice Capital Management | 112k | $1.2M | 0% | Dec 2023 |
|
| Jane Street | 104k | $1.1M | 100% | Dec 2023 |
|
| Laurion Capital Management | 103k | $1.1M | 100% | Dec 2023 |
|
| Barclays | 83k | $882k | 100% | Dec 2023 |
|
| HPM Partners | 61k | $656k | 100% | Dec 2023 |
|
| Citigroup | 61k | $653k | 100% | Dec 2023 |
|
| Emfo | 59k | $633k | 100% | Dec 2023 |
|
| Millennium Management | 36k | $385k | 24% | Dec 2023 |
|
| Royal Bank of Canada | 30k | $312k | 3% | Dec 2023 |
|
| Balyasny Asset Management | 29k | $307k | 100% | Dec 2023 |
|
| 683 Capital Management | 27k | $291k | 100% | Dec 2023 |
|
| Citadel Advisors | 27k | $284k | -18% | Dec 2023 |
|
| Bank of America Corporation | 25k | $269k | 46428% | Dec 2023 |
|
| Man Group | 24k | $251k | 100% | Dec 2023 |
|
| Clear Creek Financial Management | 22k | $547k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 18k | $196k | 100% | Dec 2023 |
|
| Sterling Investment Advisors | 17k | $182k | 100% | Dec 2023 |
|
| HighTower Advisors | 17k | $180k | -11% | Dec 2023 |
|
| Jump Financial | 16k | $172k | 100% | Dec 2023 |
|
| Dimensional Fund Advisors | 14k | $150k | -9% | Dec 2023 |
|
| Mirabella Financial Services | 12k | $131k | 100% | Dec 2023 |
|
| Wealth Enhancement Advisory Services | 11k | $270k | -16% | Mar 2024 |
|
| Cubist Systematic Strategies | 10k | $110k | 3327% | Dec 2023 |
|
| Lazard Asset Management | 7.7k | $82k | 100% | Dec 2023 |
|
| Simplex Trading | 3.2k | $78k | 16% | Mar 2024 |
|
| Wells Fargo & Company | 2.0k | $22k | 9% | Dec 2023 |
|
| Point72 Asia | 528.00 | $5.6k | 100% | Dec 2023 |
|
| Farther Finance Advisors | 100.00 | $1.1k | 0% | Dec 2023 |
|
| Federated Investors | 87.00 | $930.995700 | 100% | Dec 2023 |
|
Who sold out of Immunome?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank Of Montreal | Sep 2023 | 93k | $693k |
| Schonfeld Strategic Advisors | Sep 2023 | 18k | $152k |
| Bank of New York Mellon | Dec 2023 | 16k | $170k |
| Wealth Architects | Sep 2023 | 11k | $93k |
| Newbridge Financial Services Group | Dec 2023 | 225.00 | $2.4k |